Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis-Reference-Cited by-同舟云学术

Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis

Published:2011-10 Issue:11 Volume:12 Page:1004-1012
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Shaw Alice T,Yeap Beow Y,Solomon Benjamin J,Riely Gregory J,Gainor Justin,Engelman Jeffrey A,Shapiro Geoffrey I,Costa Daniel B,Ou Sai-Hong I,Butaney Mohit,Salgia Ravi,Maki Robert G,Varella-Garcia Marileila,Doebele Robert C,Bang Yung-Jue,Kulig Kimary,Selaru Paulina,Tang Yiyun,Wilner Keith D,Kwak Eunice L,Clark Jeffrey W,Iafrate A John,Camidge D Ross

Publisher

Elsevier BV

Subject

Oncology

Reference33 articles.

1. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

2. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer;Rikova;Cell,2007

3. EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer;Koivunen;Clin Cancer Res,2008

4. The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS;Wong;Cancer,2009

5. Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts;Takeuchi;Clin Cancer Res,2008

Cited by 804 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review on Anaplastic Lymphoma Kinase (ALK) Rearrangements and Mutations: Implications for Gastric Carcinogenesis and Target Therapy;Current Protein & Peptide Science;2024-09

2. Crizotinib and its enantiomer suppress ferroptosis by decreasing PE-O-PUFA content;Cell Death Discovery;2024-08-12

3. Conserved features and diversity attributes of chimeric RNAs across accessions in four plants;Plant Biotechnology Journal;2024-08

4. Overcoming Chemoresistance in Cancer: The Promise of Crizotinib;Cancers;2024-07-07

5. MRI radiomics predicts the efficacy of EGFR-TKI in EGFR-mutant non-small-cell lung cancer with brain metastasis;Clinical Radiology;2024-07